12 Fluid, Electrolyte, and Endocrine Problems
Pearls
• The term osmolality refers to the concentration of solute (electrolytes and proteins) per liter of fluid. Serum osmolality reflects extracellular fluid osmolality. It can be estimated with the following formula:
Note: This formula does not reflect the influence of plasma proteins or administered osmotic agents such as mannitol. It may be inaccurate in the presence of severe hyperglycemia and hyperlipemia.
• Acute changes in serum sodium and osmolality can cause acute water shifts between the intracellular and extracellular spaces. An acute fall in serum sodium concentration and osmolality and the resulting intracellular water shift can cause cerebral edema. If neurologic symptoms develop, urgent treatment is needed. In general, significant water shifts into and out of the vascular space are poorly tolerated.
• Critical care practitioners use the child’s estimated maintenance fluid requirement as a baseline and individualize administered fluid and electrolytes to meet patient needs.
• With the development of acidosis or alkalosis, the serum potassium concentration will change in a direction opposite the change in serum pH, in response to reciprocal potassium and hydrogen ion shifts into and out of the cell.
• If the level of consciousness of the child with diabetic ketoacidosis (DKA) deteriorates during treatment, cerebral edema may be present and urgent intervention is needed. If clinical signs of cerebral edema develop, immediate treatment with intravenous (IV) mannitol or hypertonic saline is needed. If the child’s ability to protect the airway or spontaneous ventilation deteriorates, intubation and mechanical ventilation are indicated.
Introduction
Small disruptions in fluid or electrolyte homeostasis or endocrine function can result in significant clinical changes in critically ill infants and children. These disruptions may be a primary problem, or they may be secondary to critical illness, critical injury, or therapeutic interventions (e.g., medication administration, fluid resuscitation).
Anatomy and physiology
Body fluids contain water and solutes. These solutes are positively or negatively charged electrolytes (e.g., Na+, K+, Cl−) and nonelectrolytes (e.g., glucose, urea). Fluid and electrolyte homeostasis is present when fluid and electrolyte balance is maintained within narrow limits despite significant variations in dietary intake, metabolic rate, and renal function.
Fluid Compartments
Water accounts for 65% to 80% of total body weight. The total body water (TBW) volume and distribution are influenced by factors such as age, gender, adipose content, and skeletal muscle mass (Table 12-1). TBW is divided into two compartments (see Evolve Table 12-1 and Evolve Fig. 12-1 in the Chapter 12 Supplement on the Evolve Website for more information): intracellular fluid (ICF) and extracellular fluid (ECF) compartments (Fig. 12-1).

Fig. 12-1 Body fluid compartments showing values for an average 70-kg person.
(From Guyton AC, Hall JE, editors: Textbook of medical physiology, ed 11. Philadelphia, 2006, WB Saunders, p. 292, Fig. 29-1.)
ICF Compartment
The ICF is within the cell membranes. It is the largest fluid compartment, comprising approximately 33% of body weight by 1 year of age. Potassium and phosphate are the primary intracellular electrolytes.
ECF Compartment
The ECF is composed of intravascular fluid (plasma or serum), interstitial fluid (lymph), and transcellular water. The ECF comprises almost half of the body weight in the full-term infant; this percentage declines as the child grows.
Sodium and chloride are the primary electrolytes of the ECF. Although the largest volume within the ECF is interstitial fluid (20% of TBW), it is the plasma or intravascular volume that is essential to cardiac output and systemic perfusion. Transcellular water typically accounts for a small percentage of TBW and is found in the pleural, pericardial, peritoneal, and joint spaces. During some disease states, the volume of transcellular fluid increases.
Fluid Shifts
Fluid compartments are separated by selectively permeable membranes. These membranes permit movement of water and some solutes (e.g., electrolytes) from one compartment to another. This movement of fluids and electrolytes occurs through osmosis, diffusion, active transport, and filtration. If osmolality becomes unequal between compartments, water shifts to restore equilibrium (see section, Role of Osmolality).
Developmental Considerations
Renal function, metabolic rate, body surface area (BSA), and fluid requirements change with development. The infant kidney is unable to concentrate urine until approximately 3 months of age, and it is relatively inefficient at concentrating urine until approximately 2 years of age. In the first years of life the kidneys are also inefficient at excreting electrolytes and waste products, and they are unable to effectively conserve or excrete sodium, acidify urine, or handle large quantities of solute-free water. As a result, infants and small children are less able to maintain homeostasis with sudden, acute changes in fluid and electrolyte intake or output.
Energy requirements (per kilogram body weight) and metabolic rate are higher in infancy and childhood (for further information, see Chapter 14). The ratio of BSA to volume is significantly higher in infants and children than in adults. As a result, pediatric evaporative fluid losses and fluid requirements per kilogram body weight are higher than those of adults.
Insensible water loss (IWL) is fluid lost through the skin, via evaporation and sweat, and through the respiratory tract. Normal IWL is approximately 300 to 400 mL/m2 BSA per day (for more detailed information, see Evolve Table 12-2 in the Chapter 12 Supplement on the Evolve Website). Fever increases IWL by approximately 0.42 mL/kg per hour for each degree Celsius increase above 37° C. Increased IWL can occur with increased air movement across the skin, and with tachypnea, unless inspired air is humidified. IWL decreases when ambient and inspired air are humidified.
Table 12-2 Formulas for Estimating Daily Maintenance Fluid and Electrolyte Requirements for Children
Daily Requirements | Hourly Requirements | |
Fluid Requirements Estimated from Weight* | ||
Newborn (up to 72 hr after birth) | 60-100 mL/kg (newborns are born with excess body water) | – |
Up to 10 kg | 100 mL/kg (can increase up to 150 mL/kg to provide caloric requirements if renal and cardiac function are adequate) | 4 mL/kg |
11-20 kg | 1000 mL for the first 10 kg + 50 mL/kg for each kg over 10 kg | 40 mL for first 10 kg + 2 mL/kg for each kg over 10 kg |
21-30 kg | 1500 mL for the first 20 kg + 25 mL/kg for each kg over 20 kg | 60 mL for first 20 kg + 1 mL/kg for each kg over 20 kg |
Fluid Requirements Estimated from Body Surface Area (BSA) | ||
Maintenance | 1500 mL/m2 BSA | – |
Insensible losses | 300-400 mL/m2 BSA | – |
Electrolytes | ||
Sodium (Na) | 2-4 mEq/kg | – |
Potassium (K) | 1-2 mEq/kg | – |
Chloride (Cl) | 2-3 mEq/kg | – |
Calcium (Ca) | 0.5-3 mEq/kg | – |
Phosphorous (Phos) | 0.5-2 mmol/kg | – |
Magnesium (Mg) | 0.4-0.9 mEq/kg | – |
* The “maintenance” fluids calculated by these formulas must only be used as a starting point to determine the fluid requirements of an individual patient. If intravascular volume is adequate, children with cardiac, pulmonary, or renal failure or increased intracranial pressure should generally receive less than these calculated “maintenance” fluids. The formula utilizing body weight generally results in a generous “maintenance” fluid total.
Fluid and electrolyte requirements will vary with age and clinical condition. Normal baseline fluid and electrolyte requirements are listed in Table 12-2. Critical care practitioners use estimated maintenance fluid requirements as a baseline and individualize administered fluid and electrolytes to meet patient needs.
Fluid, Electrolyte, and Glucose Balance
Role of Osmolality
The term osmolality refers to the concentration of solute (electrolytes and proteins) per liter of fluid. Serum osmolality reflects ECF osmolality. It can be estimated with the following formula*:
Because sodium is the primary electrolyte that determines serum osmolality, a major increase or decrease in serum sodium concentration will increase or decrease the serum osmolality, respectively.
Changes in the osmolality of one body fluid compartment will affect all other compartments. Water shifts between the ICF and the ECF compartments in response to changes in the osmolality of either compartment, moving from the compartment of lower osmolality to the compartment of higher osmolality until osmolality equilibrates. When the osmolality of the extracellular compartment (including the vascular space) decreases, water will shift from the extracellular compartment into cells (Fig. 12-2). Conversely, when the osmolality of the extracellular compartment (including the vascular space) increases, water will shift from the intracellular to the extracellular compartment (including into the vascular space). The volume and acuity of the water shift, as well as likely clinical significance, is determined by the magnitude and acuity of the osmolality gradient between compartments. Significant water shifts can cause neurologic complications.

Fig. 12-2 Water shifts with changes in serum sodium and osmolality. A, Normal. Free water shifts between extracellular and intracellular compartments and across the semipermeable vascular membrane (between the vascular and interstitial spaces) to maintain osmotic equilibrium. B, Effects of acute fall in serum osmolality. An acute fall in serum sodium and osmolality cause water to shift from the extracellular (including the vascular space) to the intracellular compartment. Intracellular water volume increases until osmolality equilibrates. The smaller inside circle (under the word “Intracellular”) represents original cell size. The black arrows schematically represent the effects of the shift of water into the intracellular compartment. C, Effects of acute rise in serum osmolality. An acute rise in serum sodium and osmolality cause water to shift from the intracellular to extracellular (including into vascular space) compartment. Intracellular water volume decreases until osmolality equilibrates. The larger outside circle (under the word “Intracellular”) represents original cell size. The arrows schematically represent the effects of the shift of free water from the intracellular to the extracellular compartment.
Renal Influences
The kidneys help maintain fluid balance through filtration and selective reabsorption. Changes in the glomerular filtration rate (GFR) alter the amount of water and sodium excreted or reabsorbed by the kidneys. Expansion of intravascular volume normally increases the GFR, increasing sodium and water excretion. When intravascular volume is depleted, the GFR falls and sodium and water excretion decrease (i.e., more sodium and water are reabsorbed into plasma from the renal filtrate). As noted previously, the kidney is less able to concentrate urine during the first months of life. (See Chapter 13 for more detailed information.)
Endocrine Influences
Several hormones contribute to regulation of fluid and electrolyte balance.
Antidiuretic Hormone (ADH, Vasopressin)
ADH, also known as vasopressin and as arginine vasopressin, is manufactured in the hypothalamus and stored in and released by the posterior pituitary in response to a rise in serum osmolality, a decrease in circulating blood volume (volume depletion), or a decrease in blood pressure. ADH acts on vasopressor-2 receptors of cells in the renal collecting ducts and distal tubules, increasing the permeability of these cells to water; this results in reabsorption of water from the filtrate and returns water to the circulation. Urine volume decreases and urine concentration increases. ADH secretion does not influence the rate of sodium reabsorption, but the serum sodium concentration typically falls because it is diluted by the reabsorbed water.
Negative feedback mechanisms normally regulate ADH secretion to maintain a serum osmolality of 275 to 295 mOsm/L. Osmolality receptors located in the brain are stimulated by a rise in serum osmolality (e.g., above 285 mOsm/L or a rise of at least 2%). Volume-sensitive receptors (located in the left atrium and thoracic vessels) and baroreceptors (stretch receptors located in the ascending aorta, pulmonary arteries, and carotid sinus) are stimulated by volume depletion and hypotension. Additional causes of ADH secretion include stress, trauma and severe pain (through activation of cholinergic neurotransmitters in the hypothalamus), angiotensin II, and some medications.3 A normal or low serum osmolality, hypertension, and an increase in left atrial stretch should inhibit ADH secretion.
Although endogenous ADH does not affect vascular tone, exogenous (administered) vasopressin can cause vasoconstriction and increase blood pressure. For further information regarding use vasopressin, see Chapters 6 and 14.
Aldosterone
Aldosterone, a mineralocorticoid, is secreted by the adrenal cortex in response to sodium depletion, hyperkalemia, or elevated levels of angiotensin II or adrenocorticotrophic hormone. Aldosterone increases sodium reabsorption by the intestine, the renal distal tubules, and collecting ducts; this increases both sodium and water reabsorption. Aldosterone increases renal secretion of potassium and hydrogen ions.
Natriuretic Peptides
The natriuretic peptides are salt-losing hormones that influence blood volume and blood pressure. Atrial natriuretic peptide (ANP) is synthesized, stored, and released by atrial myocytes in response to atrial distension, endothelin, and sympathetic nervous system and angiotensin II stimulation. Increased ANP is present during hypervolemia and congestive heart failure.
Brain natriuretic peptide is synthesized in the brain and in the ventricles of the heart. Brain natriuretic peptide release is triggered by the same conditions that trigger ANP release, and it has similar physiologic actions. Brain natriuretic peptide is a sensitive diagnostic marker for heart failure (see Congestive Heart Failure in Chapter 8).
Natriuretic peptides are involved in the long-term regulation of sodium and water balance, blood volume, and blood pressure. These hormones decrease aldosterone release, increase GFR, produce natriuresis (sodium excretion in urine) and diuresis (potassium sparing), and they decrease renin release, thereby decreasing angiotensin II. These actions reduce blood volume and central venous pressure, cardiac output, and arterial blood pressure. Chronic elevation of natriuretic peptides appears to decrease arterial blood pressure primarily by decreasing systemic vascular resistance.
Serum Glucose in Critically Ill or Injured Children
Although a serum glucose concentration of 60 to 180 mg/dL is normally maintained over a wide range of conditions, critically ill or injured children often develop hypoglycemia or hyperglycemia. Infants have high glucose needs and low glycogen stores, so they can rapidly become hypoglycemic during critical illness or injury.24 Providers should monitor serum glucose concentration with point-of-care testing, if possible, and treat hypoglycemia as needed. Treatment of hypoglycemia should avoid frequent, intermittent bolus administration of large quantities of glucose; provision of a continuous source of glucose is preferable.
Hyperglycemia can result from steroid administration, stress response, relative hypoinsulinemia, or insulin resistance and has been associated with increased mortality in critically ill children in some studies. A prospective, randomized study of tight control of serum glucose concentration in critically ill children (targeted to age-adjusted normal fasting glucose concentration) reduced critical care unit mortality,37 but was associated with episodes of hypoglycemia. In general, an insulin infusion (0.5-1 unit regular insulin/kg per hour) is often titrated during the first 18 to 24 hours of critical care therapy to maintain the serum glucose concentration less than 150 mg/dL (range will vary; use your unit protocol). Careful monitoring is required to avoid and treat episodes of hypoglycemia. The ultimate value versus risk of this approach is still under investigation.
Electrolyte homeostasis and common imbalances
Table 12-3 presents a summary of electrolyte imbalances and associated clinical manifestations in critically ill infants and children. In the following sections, approximate ranges for normal and abnormal serum electrolyte concentrations are listed, but providers should use normal ranges referenced by the clinical laboratory in their practice settings.
Sodium Homeostasis
Sodium (Na+), the primary extracellular cation, plays an important role in the regulation of action potentials in skeletal muscles, nerves, and the myocardium; maintenance of acid-base balance; and maintenance of ECF balance. The normal serum sodium concentration is approximately 135 to 145 mEq/L.
Alterations in sodium and fluid balance often occur concurrently and can alter serum osmolality. An abnormal serum sodium concentration often results from fluid volume deficit or excess. GFR and aldosterone secretion both affect sodium balance.
Sodium Imbalance: Hyponatremia
Etiology
Hyponatremia is a low serum sodium concentration, typically less than 130 to 135 mEq/L. It often develops as a complication of disease or therapy. The critically ill infant or child can develop hyponatremia from excessive water intake relative to sodium, excess water retention, increased sodium loss, or a combination of these factors.10
Hyponatremia can occur in conjunction with hypervolemia, euvolemia, or hypovolemia. Hypervolemic hyponatremia is associated with water intoxication, nephrotic syndrome, cardiac failure, renal failure, and the syndrome of inappropriate antidiuretic hormone (SIADH). Hypovolemic hyponatremia can occur with renal losses (e.g., osmotic diuresis, renal tubular acidosis) or extrarenal losses (e.g., diarrhea, vomiting, burns).10 Other potential causes include adrenal insufficiency, excessive use of diuretics, and cerebral salt-wasting syndrome.
Because the serum osmolality is determined by the combined effects of particles (solutes) in the serum—especially the sodium, glucose, and blood urea nitrogen—the serum osmolality can be normal if a fall in the concentration of one solute is accompanied by a commensurate (in osmotic effect) increase in the concentration of another solute. With significant hyperglycemia, the high glucose concentration increases serum osmolality, drawing fluid into the vascular space; this may artificially reduce the serum sodium concentration. The significance of this dilutional effect is debatable—the serum sodium concentration may still influence osmotic changes to which the cells are exposed. To estimate the potential effect of severe hyperglycemia on the serum sodium concentration, for every 100 mg/dL rise in serum glucose above normal, the serum sodium concentration is likely to be depressed approximately 1.6 mEq/L below 135 mEq/L.
Pathophysiology and Clinical Signs and Symptoms
An isolated decrease in serum sodium concentration (i.e., without a rise in glucose or blood urea nitrogen) reduces serum osmolality; an acute fall in serum osmolality produces a shift of water from the extracellular compartment (including vascular space) to the intracellular compartment. This fluid shift can cause swelling of cells (edema). Because there is limited capacity for volume expansion within the skull, swelling of brain cells (cerebral edema) can have catastrophic consequences, such as brain herniation and death.
The volume of water shift and the severity of clinical manifestations with hyponatremia are directly related to the acuity and the magnitude of the fall in serum sodium and osmolality. Infants and children who develop hyponatremia that gradually worsens over several days or weeks (e.g., with adrenocortical insufficiency) typically have milder clinical manifestations and may be asymptomatic until the serum sodium is very low.26
Acute hyponatremia that develops within hours or days (i.e., <48 hours) is more likely to produce cerebral edema.26 Seizures and coma are associated with a serum sodium concentration less than 120 mEq/L.
Management
If the child is at risk for hyponatremia, providers should closely monitor the child’s serum sodium concentration to detect and promptly treat hyponatremia before it becomes severe. Frequent neurologic assessments are indicated. Notify an on-call provider immediately if the child develops altered level of consciousness, seizures, or signs of increased intracranial pressure.
Hyponatremia associated with neurologic symptoms is a neurologic emergency. Urgent treatment includes administration of 2 to 4 mL/kg of 3% saline (513 mEq sodium/L, or 0.513 mEq/mL); this will typically raise the child’s serum sodium concentration approximately 1 to 2 mEq/L and raise serum osmolality sufficiently to slow the intracellular water shift. If the SIADH produces seizures or other severe symptoms, hyponatremia and water intoxication can be treated acutely by administration of hypertonic saline (2-4 mL/kg of 3% saline) and furosemide (1-2 mg/kg). These medications will increase the serum sodium concentration and eliminate excess free water (see section, Specific Diseases, Syndrome of Inappropriate Antidiuretic Hormone).
Management of hyponatremia includes restoration of appropriate intravascular volume, replacement of the sodium deficit, and identification and treatment of the underlying cause. Symptomatic hypovolemia is treated with boluses of normal saline or lactated Ringer’s solution. Management of hypervolemic hyponatremia may include fluid restriction and administration of loop diuretics.
Once the child’s neurologic status is stable and perfusion is adequate, plans are made to replace the sodium deficit. The following formula36 is used to calculate the sodium deficit:
During treatment of hyponatremia, providers must closely monitor the serum sodium concentration and the rate of rise in the concentration. If the serum sodium and osmolality are raised too rapidly, the resulting water shifts from the cellular to the extracellular (including intravascular) compartments can produce neurologic complications including intracranial bleeding (Box 12-1). In general, the serum sodium should be raised no faster than approximately 0.5-1.0 mEq/L per hour.35 Additional important assessments include strict monitoring of intake and output, urine specific gravity, serum electrolytes, serum osmolality, and daily weights.
Box 12-1 Advanced Concepts: Potential Central Nervous System Complications of Rapid Changes in Serum Sodium and Osmolality
The brain does not tolerate rapid or significant water shifts into and out of the cells. A shift of water into brain cells—such as that occurring with an acute fall in serum sodium concentration and serum osmolality—is likely to produce cerebral edema. A rapid shift of water from cells, including brain cells, can cause the cells to shrink and can result in cerebral dysfunction. Cells in the gray matter and tissue in the white matter in the brain swell and shrink at different rates when water shifts occur. As a result, significant water shifts between intracellular and extracellular compartments in the brain can cause tearing of cerebral bridging veins and intracranial bleeding.
Rapid correction of hyponatremia has been shown to result in cerebral dysfunction, linked with damage to the myelin sheath of neurons. This myelinolysis is called central pontine myelinolysis if it occurs in the pons (brainstem) and osmotic demyelinization syndrome if it occurs elsewhere in the brain. Signs of brain dysfunction can include decreased level of consciousness, lack of coordination, paralysis, and dysphagia. Because there is no known treatment for such cerebral dysfunction, and it can cause permanent disability, prevention is critical. In general, unless neurologic symptoms indicate the need for more aggressive treatment, providers should aim to correct hyponatremia or hypernatremia no faster than approximately 0.5 mEq/L per hour (or 10-12 mEq/L per day). For more information, consult the National Institutes of Health Web site: http://www.ninds.nih.gov/disorders/central_pontine/central_pontine_myelinolysis.htm.
Sodium Imbalances: Hypernatremia
Etiology
Hypernatremia (serum Na+ >145-150 mEq/L) occurs less frequently than hyponatremia. One of the body’s major defenses against hypernatremia is thirst. Infants, small children, and any children with significant developmental delay, decreased level of consciousness, or critical illness have an increased risk of hypernatremia during episodes of fluid loss, because they may not be able to signal caregivers of thirst or drink additional fluids.
Hypernatremia is most likely to result from a water deficit (e.g., dehydration, diuretic use, diabetes insipidus, DI). Less commonly, hypernatremia can result from excessive sodium intake, such as if powder for infant formula is incorrectly diluted. The child with hypernatremia may be hypovolemic, euvolemic, or hypervolemic; therefore, it is important to assess the child’s fluid volume status when determining the cause of the hypernatremia.
Pathophysiology and Clinical Signs and Symptoms
Hypernatremia typically increases the serum osmolality. The rise in osmolality stimulates the posterior pituitary to release ADH, which increases renal water reabsorption until the osmolality returns to normal. The increased osmolality associated with hypernatremia also leads to a shift in water from the intracellular to the extracellular compartment, including into the vascular space. This water movement from the cells can cause cellular dehydration and central nervous system dysfunction. Complications including subdural, subarachnoid, and intracerebral bleeding and sinus vein thrombosis can develop with acute and severe increases in serum sodium concentration and the resulting water shift (see Box 12-1). Permanent central nervous system dysfunction can result when the serum sodium concentration is extremely high (e.g., >165-170 mEq/L).12 When serum osmolality is chronically elevated, brain cells will generate idiogenic osmoles to maintain cell volume (Box 12-2).
Box 12-2 Advanced Concepts: The Role of Idiogenic Osmoles in Brain Cells
When extracellular (including serum) osmolality rises, water shifts from the intracellular to the extracellular compartment, and cells typically shrink. When the serum osmolality is chronically elevated, brain cells generate idiogenic osmoles (e.g., glycine and taurine) to help brain cells maintain normal cell volume despite a water shift to the extracellular space. These idiogenic osmoles, however, may contribute to cerebral edema if a high serum osmolality is lowered too rapidly.
Patients who are unable to produce and/or respond to ADH (e.g., patients with DI) are at risk for development of significant hypernatremia and hypovolemia. These patients must be closely monitored to detect and treat these complications before they become severe.
Management
If the patient with hypernatremia has signs of inadequate tissue perfusion (i.e., shock), administer isotonic crystalloid by bolus (20 mL/kg) until perfusion is adequate. Avoid excessive bolus fluid administration (i.e., beyond that needed to treat shock), because it can contribute to a rapid fall in serum sodium and osmolality resulting in cerebral edema and other neurologic complications (see Box 12-2).
Monitor patients for the clinical manifestations of cerebral edema throughout the course of their treatment. Management of the child with hypervolemic hypernatremia will typically involve loop diuretics and decreased sodium administration.
Potassium Homeostasis
Potassium is the primary intracellular cation (i.e., a positively charged ion). The magnitude of the transmembrane (i.e., between intracellular and extracellular) potassium gradient determines the excitability of nerve and muscle cells (including skeletal and heart muscle) and the rate of conduction of nerve impulses. Potassium also plays a significant role in the maintenance of acid-base balance.
The normal serum potassium (K+) concentration is 3.0 to 5.0 mEq/L. The intracellular potassium concentration is much higher, approximately 150 mEq/L.28 Small alterations in serum potassium concentration can significantly affect the transmembrane gradient and therefore neuromuscular and cardiac function. The serum K+ concentration is affected by potassium intake and excretion, renal regulation, and serum pH. Because the intravascular (serum) potassium concentration represents only a small proportion of the total body potassium, accurate interpretation of the child’s potassium balance requires consideration of the child’s clinical status and acid-base balance.
Potassium ions normally shift between the intra- and extracellular compartments with changes in the serum pH (see Evolve Fig. 12-2 in the Chapter 12 Supplement on the Evolve Website). When the serum hydrogen ion concentration increases (i.e., with acidosis or a fall in pH), hydrogen moves from the extracellular to the intracellular compartment, where it is buffered. To maintain a balance of cation movement across cell membranes, the intracellular movement of hydrogen ions is associated with an extracellular shift of potassium. Thus, acidosis or a fall in pH (e.g., with correction of alkalosis) is associated with a rise in serum potassium concentration. In contrast, alkalosis or a rise in serum pH (e.g., with treatment of acidosis) is associated with a fall in serum potassium, because hydrogen ion shifts out of cells and is replaced by potassium.
The kidneys play a critical role in potassium homeostasis. Renal failure limits the kidney’s ability to excrete potassium and may result in hyperkalemia (see Chapter 13).
Potassium Imbalances: Hypokalemia
Etiology
Causes of hypokalemia (serum K+ concentration <2.5 to 3.0 mEq/L) can be classified into three general categories: inadequate potassium intake (rare, but may be iatrogenic), shifts of potassium from the extracellular to the intracellular compartment (e.g., with alkalosis or a rise in serum pH), or excessive losses of potassium (see Evolve Fig. 12-3 in the Chapter 12 Supplement on the Evolve Website for more information). Critically ill patients often develop true potassium deficit following the use of diuretics, especially loop and thiazide diuretics. Some antimicrobial agents (e.g., amphotericin B or carbenicillin) can increase renal potassium losses. Hypokalemia also is associated with severe hypochloremia and the potassium-wasting Bartter’s syndrome.

Fig. 12-3 Electrocardiogram changes with hypokalemia and hyperkalemia.
(From Park MK, Guntheroth WG: How to read pediatric ECGs, ed 3, St. Louis, 1992, Mosby, p. 108.)
Because gastrointestinal fluids all contain significant amounts of potassium in the form of potassium chloride salt, vomiting, diarrhea, intestinal fistulas of the small intestine or colon, ileostomy drainage, or gastric suctioning can all result in potassium losses as well as loss of hydrogen ions and chloride.
Pathophysiology and Clinical Signs and Symptoms
The large quantity of intracellular potassium serves as a reservoir to help maintain intravascular potassium concentration despite potassium loss. When the serum potassium concentration begins to decline, some intracellular potassium, known as the exchangeable potassium, moves from the intracellular space to the extracellular compartment (including the vascular space). Only when this amount of exchangeable potassium is depleted will further extracellular potassium loss produce a fall in serum potassium concentration. Thus, the serum potassium concentration may be normal or even elevated when a total body potassium deficit is present.
Evaluation of the patient’s potassium balance is further complicated by potassium shifts between the intracellular and extracellular compartments that result from administration of some medications and with changes in acid-base balance. β-Adrenergic agonists (e.g., inhaled albuterol) can cause a fall in serum potassium, whereas α-adrenergic agents can cause a rise in serum potassium. β-Adrenergic agonists increase intracellular sodium ion movement that stimulates the sodium-potassium pump to move sodium out of the cells. For every three sodium ions pumped out of cells, two potassium ions are allowed to enter cells. Thus, potassium shifts from the extracellular (including vascular) to the intracellular space.
Alpha-adrenergic agents can cause a rise in serum potassium, because potassium shifts from the intracellular to the extracellular (including vascular) space. Insulin administration can produce a fall in the serum potassium concentration, because insulin stimulates cellular uptake of potassium.
Acute alkalosis or a rise in serum pH (e.g., during treatment of acidosis) will cause a fall in serum potassium concentration, because hydrogen ion shifts out of the cell and is replaced by potassium (i.e., potassium moves into the cells). If the serum potassium concentration is within the normal range and the child’s serum pH then rises (e.g., as occurs with treatment of acidosis) hypokalemia may result.
Hypokalemia may also result from increased renal potassium excretion. This hypokalemia can be associated with metabolic alkalosis, renal tubular acidosis, and DKA. Hypokalemia can perpetuate metabolic alkalosis, particularly if either condition is chronic. When the serum potassium concentration is low, the kidney vigorously reabsorbs potassium and must excrete hydrogen ions. As a result, it may be necessary to treat the child’s hypokalemia to correct significant alkalosis.
Excessive renal potassium losses can also result from increased mineralocorticoid activity and increased delivery of sodium to the distal nephron. Excessive renal potassium losses have been associated with administration of antibiotics such as carbenicillin (and other penicillins), amphotericin B, gentamicin and aminoglycosides. A common cause of hypokalemia in the critically ill patient is the use of diuretics, especially loop and thiazide diuretics.
Chronic hypokalemia can change renal concentrating ability and cause polyuria. The kidney has little ability to conserve potassium when body potassium stores become low; as a result, urinary potassium excretion will remain greater than 20 mEq/L once hypokalemia persists for 10 to 20 days.
Although some potassium is lost with vomiting, diarrhea, and loss of other gastrointestinal fluids, potassium losses are exacerbated by intravascular volume contraction. Hypovolemia stimulates aldosterone secretion, which produces sodium and water retention, but it increases hydrogen ion and potassium excretion.
Hypokalemia can cause hyperpolarization of nerve and muscle cells, leading to muscle weakness, slowed nerve impulse conduction, and decreased muscle contraction. Hypokalemia can cause characteristic electrocardiogram (ECG) changes, including development of a U-wave (Fig. 12-3).

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

